Zhejiang Nutrition and Health Study (NuLife)

August 25, 2023 updated by: Jusheng Zheng, Westlake University

Zhejiang Nutrition and Health Study: Nutrition and Lifespan Study (NuLife Study)

This project aims to explore the relationship between healthy lifespan and nutrition through a 10-year longitudinal study in Zhejiang Province. The cohort will include individuals in a wide range of age groups. The demographic, diet, lifestyle information, health status, and corresponding bio-samples will be collected carefully. It will give a deeper insight to the relation between nutrition and healthy aging and longevity. Ultimately, this research will contribute to evidence-based nutrition interventions to improve health outcomes and enhance quality of life.

Study Overview

Detailed Description

This project aims to elucidate the relationship between healthy lifespan and nutrition through the establishment of a large-scale cohort of participants and longitudinal follow-ups spanning around 10 years in Zhejiang Province. The cohort will comprise individuals in a wide range of age groups starting at 6 years old. The participants will provide demographic information, anthropometry measurements, detailed diet, lifestyle data and health status, including 3-day dietary records and long-term food intake frequency recalls. Integrated with previous information, diverse bio-samples will also be collected to establish a multi-dimensional biobank. It will give a deeper insight to the relation between nutrition and healthy aging and longevity. Ultimately, this research will contribute to the development of evidence-based nutrition designed to improve health outcomes and enhance the quality of life for individuals of all ages.

Study Type

Observational

Enrollment (Estimated)

10000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

    • Zhejiang
      • Hangzhou, Zhejiang, China, 310052
        • Recruiting
        • Zhejiang Provincial Center for Disease Control and Prevention
        • Contact:
          • Danting Su, Master
          • Phone Number: 86-0571-87115262
          • Email: dtsu@cdc.zj.cn
        • Contact:
          • Dan Han, Master
          • Phone Number: 86-0571-87115324
          • Email: dhan@cdc.zj.cn
        • Principal Investigator:
          • Ronghua Zhang, Master
      • Hangzhou, Zhejiang, China
        • Recruiting
        • Westlake University
        • Contact:
        • Principal Investigator:
          • Ju-Sheng Zheng, PhD
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

Permanent residents in Zhejiang Province

Description

Inclusion Criteria:

  • Chinese citizens who have resided in the surveyed area for at least 6 months before the survey within the last 12 months.
  • Aged 6 years or older.
  • They are included as resident households, which are comprised of people living together in one place based on family relationships, and at least one resident with permanent household registration.

Exclusion Criteria:

  • Residents living in functional zones such as construction worker dormitories, military barracks, schools, nursing homes, etc.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Occurrence of cardio-metabolic diseases
Time Frame: up to 10 years
The investigators will track for occurrence of cardio-metabolic diseases by follow-up surveys collected by the Zhejiang Center for Disease Control and Prevention.
up to 10 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in fasting blood glucose
Time Frame: Every other year, up to 10 years
Fasting glucose will be examined in mmol/L.
Every other year, up to 10 years
Changes in fasting blood HbA1c
Time Frame: Every other year, up to 10 years
Fasting blood HbA1c will be examined in %
Every other year, up to 10 years
Changes in fasting lipid metabolism
Time Frame: Every other year, up to 10 years
Triglyceride, cholesterol, high density lipoprotein cholesterol and low density lipoprotein cholesterol will be examined in mmol/L.
Every other year, up to 10 years
Changes in fasting blood highly sensitive C-reactive protein (CRP)
Time Frame: Every other year, up to 10 years
CRP will be examined in mg/L.
Every other year, up to 10 years
Changes in body mass index
Time Frame: Every other year, up to 10 years
Body mass index (BMI) will be calculated in kg/m^2
Every other year, up to 10 years
Changes in blood pressure
Time Frame: Every other year, up to 10 years
Blood pressure, including systolic and diastolic blood pressure, will be measured in mmHg
Every other year, up to 10 years
Changes in gut microbiome profiling
Time Frame: Every other year, up to 10 years
16S rRNA and/or shotgun metagenomic sequencing will be performed in stool samples.
Every other year, up to 10 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ju-Sheng Zheng, PhD, Westlake University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 19, 2023

Primary Completion (Estimated)

July 1, 2033

Study Completion (Estimated)

July 1, 2033

Study Registration Dates

First Submitted

June 26, 2023

First Submitted That Met QC Criteria

July 3, 2023

First Posted (Actual)

July 5, 2023

Study Record Updates

Last Update Posted (Actual)

August 29, 2023

Last Update Submitted That Met QC Criteria

August 25, 2023

Last Verified

August 1, 2023

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 20230511JZS001

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases

3
Subscribe